RNU6-1028P

Across TCGA pan-cancer cohorts, RNU6-1028P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-1028P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-1028P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1028P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

UCEC, LUSC, and OV are the cancer types where RNU6-1028P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.694	0.901	<.001	108	view →
LUSC	OS	Tertile	All	0.498	0.778	.006	36	view →
OV	OS	Tertile	III,IV	0.674	0.309	.034	36	view →
ACC	DFS	Tertile	All	0.066	0.667	.002	36	view →
SARC	OS	Tertile	All	0.078	0.867	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	30	view →
COAD	DFS	Tertile	II,III,IV	0.215	0.662	.021	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
LIHC	DFS	Tertile	All	0.054	0.553	<.001	18	view →
KIRP	OS	Tertile	All	0.680	0.903	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-1028P–UCEC (DFS)

Open the UCEC breakdown →